Legislation - HB0417

Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.

Committees

Original:: Health Click to view Recorded Media

Opposite:: Finance

Committee Testimony

Witness List

Details

Cross-filed with: SB0435

Introduced in a prior session as: HB1109 Session: 2025 Regular Session

Bill File Type: Regular

Effective Date(s): October 1, 2026

History

Legislation History
Chamber House Calendar Date 1/22/2026 Legislative Date 1/22/2026 Action First Reading Health Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Public Health - Medetomidine and Xylazine Consumer Protection Act Proceedings
Chamber House Calendar Date 1/22/2026 Legislative Date 1/22/2026 Action Hearing 2/10 at 2:00 p.m. Proceedings
Chamber House Calendar Date 2/10/2026 Legislative Date 2/10/2026 Action Hearing canceled Proceedings
Chamber House Calendar Date 2/10/2026 Legislative Date 2/10/2026 Action Hearing 2/10 at 2:30 p.m. Proceedings
Chamber Calendar Date Legislative Date Action Vote - House - Committee - Health Proceedings Click to view Recorded Media
Chamber House Calendar Date 3/03/2026 Legislative Date 3/03/2026 Action Favorable with Amendments Report by Health Proceedings
Chamber House Calendar Date 3/03/2026 Legislative Date 2/22/2026 Action Favorable with Amendments {953328/1 Adopted Proceedings 31 Click to view Recorded Media
Chamber House Calendar Date 3/03/2026 Legislative Date 2/22/2026 Action Second Reading Passed with Amendments Proceedings 31 Click to view Recorded Media
Chamber Calendar Date Legislative Date Action Text - Third - Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine Proceedings
Chamber House Calendar Date 3/04/2026 Legislative Date 2/23/2026 Action Third Reading Passed (127-0) Proceedings 32 Click to view Recorded Media
Chamber Senate Calendar Date 3/05/2026 Legislative Date 2/22/2026 Action Referred Finance Proceedings 33 Click to view Recorded Media

Chamber	Calendar Date	Legislative Date	Action	Proceedings
House	1/22/2026	1/22/2026	First Reading Health
			Text - First - Public Health - Medetomidine and Xylazine Consumer Protection Act
House	1/22/2026	1/22/2026	Hearing 2/10 at 2:00 p.m.
House	2/10/2026	2/10/2026	Hearing canceled
House	2/10/2026	2/10/2026	Hearing 2/10 at 2:30 p.m.
			Vote - House - Committee - Health	Click to view Recorded Media
House	3/03/2026	3/03/2026	Favorable with Amendments Report by Health
House	3/03/2026	2/22/2026	Favorable with Amendments {953328/1 Adopted	31 Click to view Recorded Media
House	3/03/2026	2/22/2026	Second Reading Passed with Amendments	31 Click to view Recorded Media
			Text - Third - Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
House	3/04/2026	2/23/2026	Third Reading Passed (127-0)	32 Click to view Recorded Media
Senate	3/05/2026	2/22/2026	Referred Finance	33 Click to view Recorded Media

File Code

Subjects

Statutes